Caris Life Sciences
Delivers tissue and blood molecular profiling for oncology care and biopharma research.
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 282.68M · Float 11.29M · 4.0% free float
A Form 4 total here can count shares the filer formally disclaims — an award voted by proxy, for instance — which the holder's own Schedule 13D/G excludes, so where the two disagree the schedule's smaller figure is used.
Institutions13F, as of Jun 30, 2026
255 holders · 149.70M shares · 70 new positions · 176 increased · 47 reduced · 25 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 30.92M | 10.94% | +138.3K | Aug 13, 2026 |
| J. H. Whitney Equity Partners Vi, LLC | 11.26M | 3.98% | −7.00M | Aug 12, 2026 |
| Coatue Management LLC | 9.82M | 3.47% | 0 | Aug 14, 2026 |
| Braidwell LP | 8.26M | 2.92% | +246.6K | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | 7.33M | 2.59% | −7.06M | Aug 14, 2026 |
| Pointstate Capital LP | 6.83M | 2.42% | −531.6K | Aug 14, 2026 |
| JPMorgan Chase & Co | 6.56M | 2.32% | +3.10M | Aug 12, 2026 |
| BlackRock, Inc. | 5.54M | 1.96% | +679.7K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| David D. Halbert | 44.10% | 124.91M | 13G | Aug 13, 2025 ↗ |
| FMR LLC | 10.80% | 30.63M | 13G | Apr 7, 2026 ↗ |
| TSSP Sub-Fund HoldCo, LLC | 8.30% | 23.17M | 13G | Jul 28, 2025 ↗ |
| J H Whitney VI LP | 7.30% | 20.26M | 13G | Aug 14, 2025 ↗ |
| J H Whitney VI L P | 6.50% | 18.26M | 13G | May 12, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| David D. Halbert | director, 10 percent owner, officer: See Remarks | 123.60M | 43.72% | May 18, 2026 |
| J H Whitney VI L P | 10 percent owner | 18.26M | 6.46% | Jun 23, 2025 |
| ADAPT I Ltd. | 10 percent owner | 16.94M | 5.99% | Jun 23, 2025 |
| Peter M. Castleman | director | 10.30M | 3.64% | Aug 14, 2026 |
| Jon Halbert | director | 836.4K | 0.30% | Aug 14, 2026 |
| Brian J. Brille | director, officer: See Remarks | 730.3K | 0.26% | May 18, 2026 |
| David Baxley Spetzler | officer: President | 530.1K | 0.19% | May 18, 2026 |
| TSSP Sub-Fund HoldCo LLC | other: Former 10% Owner | 478.8K | 0.17% | Jun 23, 2025 |
| Laura I. Johansen | director | 343.9K | 0.12% | Aug 14, 2026 |
| George Poste | director | 325.3K | 0.12% | Jun 2, 2026 |
3 ten-percent owners hold 35.68M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 7 people have not refiled in the last 18 months (184.3K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 15, 2026 | Jon Halbertdirector | Purchase | 68,000 | $14.56 | 704,598 |
| May 11, 2026 | Jeff L. Vacircadirector | Purchase | 31,050 | $16.15 | 49,671 |
| Dec 11, 2025 | Luke Thomas Powerofficer: See Remarks | Sale · 2 lots | 62,250 | $26.58 | 99,571 |
| Nov 7, 2025 | David Baxley Spetzlerofficer: President | Purchase | 400 | $23.85 | 460,777 |
| Nov 7, 2025 | John Russel Dentonofficer: See Remarks | Purchase | 4,184 | $24.09 | 9,184 |
CongressHouse and Senate disclosures
Not reported.